{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:33:19Z","timestamp":1793237599329,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Although there is evidence regarding the effectiveness of probiotics for infantile colic (IC), there are not many studies regarding the efficacy of Bifidobacterium animalis subsp. Lactis BB-12\n                      <jats:sup>\u00ae<\/jats:sup>\n                      , (BB-12\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ), for the treatment of IC. This trial aimed to evaluate the efficacy of this subspecies of probiotic administration on IC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      In this double-blind randomized, placebo-controlled clinical trial, infants with IC diagnosis, exclusive breastfeeding, gestational age of more than 37 weeks, and birth weight of more than 2500 grams were included. The selected infants were randomly allocated into the two groups of \u201cBBcare\u201d group, treated with BB-12\n                      <jats:sup>\u00ae<\/jats:sup>\n                      and the control group was treated with a placebo, 5 drops per day, for 6 weeks. The mean of crying time, vomiting episodes, and frequency of defecation at baseline and during follow-ups (40 and 60 days after intervention) were compared between the two studied groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In this study, 40 and 38 neonates in \u201cBBcare\u201d and placebo groups completed the study. In the \u201cBBcare\u201d group frequency of defecation, crying time, and vomiting episodes decreased significantly during intervention till 60 days after probiotic administration (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). In the placebo group, there was a significant increase in crying and vomiting episodes between baseline and 60 days after intervention (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Between-group analyses indicated that mean of crying time, and vomiting episodes and number of defecations, 60 days after intervention were significantly lower in \u201cBBcare\u201d group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The findings of our study offer compelling signals for the effectiveness of BB-12\n                      <jats:sup>\u00ae<\/jats:sup>\n                      in the management of some intestinal problems. Although these findings could be supportive evidence for the important role of gut microbiota as the goal of intervention to improve bowel movement and comfortable defecation in IC, further studies are needed in this field, especially for the evaluation of different types of probiotics in combination with each other\u2019s and with different dosages.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_185_24","type":"journal-article","created":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:00:15Z","timestamp":1793210415000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Efficacy of the Administration of Bifidobacterium lactis for Treatment of Infantile Colic: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial"],"prefix":"10.4103","volume":"15","author":[{"given":"Mohammad Ali","family":"Pourmirzaiee","sequence":"first","affiliation":[{"name":"Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Famouri","sequence":"additional","affiliation":[{"name":"Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Metabolic Liver Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Imam Hossein Children\u2019s Hospital, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Kahied","sequence":"additional","affiliation":[{"name":"Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silva","family":"Hovsepeian","sequence":"additional","affiliation":[{"name":"Metabolic Liver Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Imam Hossein Children\u2019s Hospital, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Kalishadi","sequence":"additional","affiliation":[{"name":"Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4]]},"reference":[{"key":"R2-20261029","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41575-018-0008-7","article-title":"Infant colic: Mechanisms and management","volume":"15","author":"Zeevenhooven","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20261029","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/5584_2018_315","article-title":"Preventing and treating colic","volume":"1125","author":"Indrio","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"R4-20261029","doi-asserted-by":"crossref","first-page":"573","DOI":"10.31128\/AJGP-07-21-6062","article-title":"Effectiveness of probiotics for the treatment of infantile colic","volume":"51","author":"Pereira","year":"2022","journal-title":"Aust J Gen Pract"},{"key":"R5-20261029","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/NMC.0000000000000691","article-title":"Probiotics for the management of infantile colic: A systematic review","volume":"46","author":"Simonson","year":"2021","journal-title":"MCN Am J Matern Child Nurs"},{"key":"R6-20261029","first-page":"CD012473","article-title":"Probiotics to prevent infantile colic","volume":"3","author":"Ong","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20261029","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/microorganisms2020092","article-title":"The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12\u00ae","volume":"2","author":"Jungersen","year":"2014","journal-title":"Microorganisms"},{"key":"R8-20261029","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5223\/pghn.2017.20.2.100","article-title":"Innovative dietary intervention answers to baby colic","volume":"20","author":"Xinias","year":"2017","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"R9-20261029","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.mpg.0000441931.07469.c0","article-title":"Treatments for infant colic","volume":"57","author":"Bella\u00efche","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R10-20261029","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/gut.33.6.818","article-title":"Defecation frequency and timing, and stool form in the general population: A prospective study","volume":"33","author":"Heaton","year":"1992","journal-title":"Gut"},{"key":"R11-20261029","doi-asserted-by":"crossref","first-page":"g2107","DOI":"10.1136\/bmj.g2107","article-title":"Treating infant colic with the probiotic Lactobacillus reuteri: Double blind, placebo controlled randomised trial","volume":"348","author":"Sung","year":"2014","journal-title":"BMJ"},{"key":"R12-20261029","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpeds.2014.09.020","article-title":"Probiotics for infantile colic: A randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938","volume":"166","author":"Chau","year":"2015","journal-title":"J Pediatr"},{"key":"R13-20261029","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s10482-015-0448-9","article-title":"Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: A prospective single blind randomized trial","volume":"107","author":"Mi","year":"2015","journal-title":"Antonie Van Leeuwenhoek"},{"key":"R14-20261029","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/pr.2015.127","article-title":"Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: A randomized, controlled trial","volume":"78","author":"P\u00e4rtty","year":"2015","journal-title":"Pediatr Res"},{"key":"R15-20261029","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jpc.12640","article-title":"Synbiotic in the management of infantile colic: A randomised controlled trial","volume":"50","author":"Kianifar","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"R16-20261029","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00431-014-2328-0","article-title":"The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: A review of the current evidence","volume":"173","author":"Urba\u0144ska","year":"2014","journal-title":"Eur J Pediatr"},{"key":"R17-20261029","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/apt.15561","article-title":"The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12\u00ae in infant colic: A randomised, double blind, placebo-controlled trial","volume":"51","author":"Nocerino","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R18-20261029","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1651-2227.2004.tb03025.x","article-title":"Intestinal microflora in breastfed colicky and non-colicky infants","volume":"93","author":"Savino","year":"2004","journal-title":"Acta Paediatr"},{"key":"R19-20261029","first-page":"1","article-title":"Intestinal lactobacillus species: Is it equal in colicky and non-colicky breastfed infants?","volume":"4","author":"Akbarian-Rad","year":"2013","journal-title":"Iran J Neonatol"},{"key":"R20-20261029","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/apa.13642","article-title":"Comparison of formula-fed infants with and without colic revealed significant differences in total bacteria, Enterobacteriaceae and faecal ammonia","volume":"106","author":"Savino","year":"2017","journal-title":"Acta Paediatr"},{"key":"R21-20261029","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/jcm9040999","article-title":"The effect of probiotics on symptoms, gut microbiota and inflammatory markers in infantile colic: A systematic review, meta-analysis and meta-regression of randomized controlled trials","volume":"9","author":"Skonieczna-\u017bydecka","year":"2020","journal-title":"J Clin Med"},{"key":"R22-20261029","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.3748\/wjg.14.5570","article-title":"Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells","volume":"14","author":"Latvala","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R23-20261029","doi-asserted-by":"crossref","first-page":"e01206","DOI":"10.1128\/AEM.01206-17","article-title":"Specific signatures of the gut microbiota and increased levels of butyrate in children treated with fermented cow's milk containing heat-killed Lactobacillus paracasei CBA L74","volume":"83","author":"Berni Canani","year":"2017","journal-title":"Appl Environ Microbiol"},{"key":"R24-20261029","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/apa.17036","article-title":"Probiotics for infantile colic: Is there evidence beyond doubt? A meta-analysis and systematic review","volume":"113","author":"Vaz","year":"2024","journal-title":"Acta Paediatr"},{"key":"R25-20261029","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1017\/S0007114509289069","article-title":"Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: A randomised controlled trial","volume":"102","author":"Vlieger","year":"2009","journal-title":"Br J Nutr"},{"key":"R26-20261029","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/19490976.2017.1412908","article-title":"Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial","volume":"9","author":"Ibarra","year":"2018","journal-title":"Gut Microbes"},{"key":"R27-20261029","doi-asserted-by":"crossref","first-page":"101487","DOI":"10.1016\/j.xcrm.2024.101487","article-title":"Microbiome bacterial influencers of host immunity and response to immunotherapy","volume":"5","author":"Yousefi","year":"2024","journal-title":"Cell Rep Med"},{"key":"R28-20261029","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.3390\/nu15184000","article-title":"Seeding the infant gut in early life-effects of maternal and infant seeding with probiotics on strain transfer, microbiota, and gastrointestinal symptoms in healthy breastfed infants","volume":"15","author":"Melsaether","year":"2023","journal-title":"Nutrients"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_185_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:00:23Z","timestamp":1793235623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_185_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_185_24","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2024-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}